Veliparib ne mesylate Entacapone is a COMT inhibitor

Entacapone is a COMT inhibitor used to treat Parkinson's Disease

16-6-/t15-

Destabilization of both β-catenin and Ras via targeting axin is a potential therapeutic strategy for treatment of CRC and other type cancers activated Wnt/β-catenin and Ras pathways

InChi: InChI=1S/C28H46O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26

Veliparib ne mesylate Entacapone is a COMT inhibitorVeliparib, also known as ABT 888, is a poly(ADP ribose) polymerase (PARP) 1 and 2 inhibitor with chemosensitizing and antitumor activities. With no antiproliferative effects as a single agent at therapeutic concentrations, ABT 888 inhibits PARPs, thereby inhibiting DNA repair and potentiating the cytotoxicity of DNA damaging agents. Product information CAS Number: 912444 00 9 Molecular Weight: 244. 29 Formula: C13H16N4O Chemical Name: 2 [(2R) 2